Dashboard
Manage Tickers

PRVAPrivia Health Group, Inc.

Nasdaq priviahealth.com


$ 17.03 $ 0.07 (0.41 %)    

Friday, 05-Jul-2024 13:54:14 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 496.35 $ 4.61 (0.94 %)
DIA $ 393.00 $ 0.17 (0.04 %)
SPY $ 554.47 $ 2.68 (0.49 %)
TLT $ 92.53 $ 0.45 (0.49 %)
GLD $ 220.64 $ 1.13 (0.51 %)
$ 16.95
$ 16.96
$ 16.98 x 111
$ 0.00 x 0
$ 16.87 - $ 17.16
$ 15.92 - $ 28.23
460,819
na
2.12B
$ 0.76
$ 113.11
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-25-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-28-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

insiders-buying-hilton-worldwide-and-2-other-stocks
Insiders Buying Hilton Worldwide And 2 Oth...
05/30/2024 11:16:25

baird-initiates-coverage-on-privia-health-gr-with-outperform-rating-announces-price-target-of-23
Baird Initiates Coverage On Privia Health ...
05/30/2024 10:06:09

Baird analyst Michael Ha initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Outperform rating and announces Price T...

barclays-maintains-equal-weight-on-privia-health-gr-lowers-price-target-to-19
Barclays Maintains Equal-Weight on Privia ...
05/20/2024 14:10:15

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and lowers the price target from $2...

what-12-analyst-ratings-have-to-say-about-privia-health-gr
What 12 Analyst Ratings Have To Say About ...
05/15/2024 14:00:31

truist-securities-maintains-buy-on-privia-health-gr-lowers-price-target-to-24
Truist Securities Maintains Buy on Privia ...
05/15/2024 13:55:36

Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target fr...

canaccord-genuity-maintains-buy-on-privia-health-gr-lowers-price-target-to-26
Canaccord Genuity Maintains Buy on Privia ...
05/10/2024 18:46:02

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from...

privia-health-reiterates-fy24-guidance-revenue-of-16b-1675b-est-2844b
Privia Health Reiterates FY24 Guidance; Re...
05/09/2024 10:30:36

privia-health-gr-q1-2024-adj-eps-018-beats-005-estimate-sales-415243m-miss-679999m-estimate
Privia Health Gr Q1 2024 Adj EPS $0.18 Bea...
05/09/2024 10:11:54

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.0...

stifel-maintains-buy-on-privia-health-gr-lowers-price-target-to-24
Stifel Maintains Buy on Privia Health Gr, ...
05/01/2024 13:22:07

Stifel analyst Craig Jones maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $28 to $24.

where-privia-health-gr-stands-with-analysts
Where Privia Health Gr Stands With Analysts
04/22/2024 16:00:54

citigroup-initiates-coverage-on-privia-health-gr-with-buy-rating-announces-price-target-of-25
Citigroup Initiates Coverage On Privia Hea...
04/22/2024 13:01:01

Citigroup analyst Daniel Grosslight initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Buy rating and announces Pri...

analyst-scoreboard-8-ratings-for-privia-health-gr
Analyst Scoreboard: 8 Ratings For Privia H...
03/19/2024 15:01:10

canaccord-genuity-maintains-buy-on-privia-health-gr-lowers-price-target-to-37
Canaccord Genuity Maintains Buy on Privia ...
03/19/2024 10:46:04

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from...

jp-morgan-maintains-overweight-rating-for-privia-health-gr-heres-what-you-need-to-know
JP Morgan Maintains Overweight Rating for ...
03/06/2024 17:00:35

jp-morgan-maintains-overweight-on-privia-health-gr-lowers-price-target-to-30
JP Morgan Maintains Overweight on Privia H...
03/06/2024 16:16:01

JP Morgan analyst Lisa Gill maintains Privia Health Gr (NASDAQ:PRVA) with a Overweight and lowers the price target from $38 ...

barclays-initiates-coverage-on-privia-health-gr-with-equal-weight-rating-announces-price-target-of-22
Barclays Initiates Coverage On Privia Heal...
03/06/2024 11:57:13

Barclays analyst Andrew Mok initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight rating and announces Pr...

ubs-maintains-buy-on-privia-health-gr-lowers-price-target-to-29
UBS Maintains Buy on Privia Health Gr, Low...
03/01/2024 16:52:19

UBS analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $31 to $29.

td-cowen-maintains-outperform-on-privia-health-gr-lowers-price-target-to-26
TD Cowen Maintains Outperform on Privia He...
03/01/2024 13:32:53

TD Cowen analyst Gary Taylor maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the price target from $30...

forecasting-the-future-4-analyst-projections-for-privia-health-gr
Forecasting The Future: 4 Analyst Projecti...
02/29/2024 17:01:03

truist-securities-maintains-buy-on-privia-health-gr-lowers-price-target-to-28
Truist Securities Maintains Buy on Privia ...
02/29/2024 14:23:38

Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target fr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)